A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

(2011) Kristina Magnusson et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer

(2011) A Larsson et al.   BRITISH JOURNAL OF CANCER

Correlation of SATB1 overexpression with the progression of human rectal cancer

(2011) Wen-Jian Meng et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Loss of Special AT-Rich Binding Protein 1 Expression is a Marker of Poor Survival in Lung Cancer

(2011) Christina I. Selinger et al.   Journal of Thoracic Oncology

Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study

(2011) Sakarias Wangefjord et al.   Biology of Sex Differences

The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status

(2010) A. M. Dahlin et al.   CLINICAL CANCER RESEARCH

SATB2 augments ΔNp63α in head and neck squamous cell carcinoma

(2010) Jacky Chung et al.   EMBO REPORTS

Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer

(2009) Shuang Wang et al.   JOURNAL OF PATHOLOGY

Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status

(2008) Alessandro Lugli et al.   MODERN PATHOLOGY

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis

(2008) Hye-Jung Han et al.   NATURE